Our study demonstrated strong correlations between plasma sST2 levels and key cardiac injury biomarkers, including cTnI, CK-Mb, Mb, and NT-proBNP, suggesting that sST2 is a reliable marker of myocardial injury in COVID-19 patients. This evidence concerns the gene MB and COVID-19.